For global pharmaceutical executives and research directors, the message is unmistakable: ignoring China’s clinical data and regulatory pathways is no longer a viable strategy. The…

This breakthrough transforms an environmental liability into a platform for advanced Fenton-like catalysis, a development that could reshape industrial wastewater treatment and materials lifecycle management…

China’s rapid ascent in targeted anticancer drug development is reshaping global clinical research, creating both opportunities and strategic challenges for international stakeholders in precision medicine.…

The takeaway for global health strategists: one-size-fits-all exercise guidelines may be dangerously imprecise. China’s latest evidence suggests that the protective power of physical activity is…

For the globally mobile Chinese researcher, the loss of an institutional email is more than a logistical inconvenience — it is a quiet erosion of…

For global investors and tech strategists, China’s regulatory pivot is not a retreat from market forces but a recalibration—one that is quietly redrawing the boundaries…

This study underscores that biodiversity conservation strategies must account for the nuanced interplay between growth forms and environmental gradients, a finding with direct implications for…